Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
AstraZeneca
Harvard Business School
Mallinckrodt
Moodys

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tideglusib

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Tideglusib?

Tideglusib is an investigational drug.

There have been 5 clinical trials for Tideglusib. The most recent clinical trial was a Phase 2 trial.

The most common disease conditions in clinical trials are Alzheimer Disease, Autism Spectrum Disorder, and Supranuclear Palsy, Progressive. The leading clinical trial sponsors are Noscira SA, Holland Bloorview Kids Rehabilitation Hospital, and AMO Pharma Limited.

Recent Clinical Trials for Tideglusib
TitleSponsorPhase
Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum DisordersHolland Bloorview Kids Rehabilitation HospitalPhase 2
Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum DisordersMcMaster UniversityPhase 2
Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum DisordersSt. Michael's Hospital, TorontoPhase 2

See all Tideglusib clinical trials

Clinical Trial Summary for Tideglusib

Top disease conditions for Tideglusib
Top clinical trial sponsors for Tideglusib

See all Tideglusib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Medtronic
McKinsey
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.